MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the year ending 2025-12-31.

Cash Flow Overview

Free Cash flow
-$68,882K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of equity...
    • Proceeds from maturities of mark...
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Operating lease liabilities
    • Accounts payable
    • Purchases of property and equipm...

Cash Flow
2025-12-31
Net loss
-90,597
Depreciation and amortization
8,436
Amortization (accretion) of premium (discount) on marketable securities
411
Stock-based compensation
13,046
Non-cash operating lease expense
2,473
Other
-423
Prepaid expenses and other current assets
-547
Other noncurrent assets
-571
Accounts payable
-1,430
Accrued and other current liabilities
532
Operating lease liabilities
-2,778
Other noncurrent liabilities
102
Net cash used in operating activities
-68,264
Purchases of property and equipment
618
Purchases of marketable securities
0
Proceeds from sales of marketable securities
10,958
Proceeds from maturities of marketable securities
45,743
Other
0
Net cash provided by investing activities
56,083
Proceeds from issuance of equity, net of issuance costs-Follow On Offering
105,065
Proceeds from exercise of stock options and employee stock purchase plan
139
Proceeds from exercise of warrants
2,289
Proceeds from exercises of pre-funded warrants
0
Proceeds from issuance of equity, net of issuance costs-At The Market Offering
912
Net cash provided by financing activities
108,405
Net change in cash, cash equivalents and restricted cash
96,224
Cash and cash equivalents and restricted cash at beginning of period
4,742
Cash and cash equivalents and restricted cash at end of period
100,966
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofequity, net of issuance...$105,065K Proceeds from exercise ofwarrants$2,289K Proceeds from issuance ofequity, net of issuance...$912K Proceeds from exercise ofstock options and...$139K Proceeds from maturitiesof marketable...$45,743K Proceeds from sales ofmarketable securities$10,958K Net cash provided byfinancing activities$108,405K Net cash provided byinvesting activities$56,083K Canceled cashflow$618K Net change in cash,cash equivalents and...$96,224K Canceled cashflow$68,264K Stock-based compensation$13,046K Depreciation andamortization$8,436K Non-cash operating leaseexpense$2,473K Other noncurrentassets-$571K Prepaid expenses andother current assets-$547K Accrued and othercurrent liabilities$532K Other-$423K Amortization (accretion) ofpremium (discount) on...$411K Other noncurrentliabilities$102K Purchases of property andequipment$618K Net cash used inoperating activities-$68,264K Canceled cashflow$26,541K Net loss-$90,597K Operating leaseliabilities-$2,778K Accounts payable-$1,430K

Tenaya Therapeutics, Inc. (TNYA)

Tenaya Therapeutics, Inc. (TNYA)